A bearish forecast: JPMorgan’s list of nine FTSE 250 stocks to avoid

Big money managers have smelt blood in the water, and they’re circling these nine FTSE 250 stocks. Our writer owns one of them: will he sell or hold?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Frustrated young white male looking disconsolate while sat on his sofa holding a beer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JPMorgan has gone bearish on nine FTSE 250 stocks, betting big money against them.

The bank’s decision to short these nine stocks could trigger big shareholders to re-evaluate their positions.

Short-selling involves borrowing shares to sell them in the market, with the goal of repurchasing them at a lower price.

Watch out below

The Financial Conduct Authority (FCA) makes funds disclose their net short positions once they meet or exceed 0.5% of a company’s issued share capital.

A disclosure from 14 December shows JPMorgan has shorted nine stocks in the FTSE 250 index.

Company Name                                       % of share capital shorted as at 14 December 2023
FD Technologies1.13
Vertu Motors0.75
Supermarket Income REIT0.61
Renishaw0.60
Primary Health Properties0.60
Pennon Group0.55
ME Group International0.54
The Gym Group0.54
Essentra0.52
Financial Conduct Authority disclosures, as at 14 December 2023

JPMorgan’s most heavily shorted stock is FD Technologies, a data solutions provider. In second place is Vertu Motors, an automotive dealership group. In third position is Supermarket Income REIT, an investment trust focusing on supermarket real estate.

Worryingly, I have a sizeable position in my own portfolio of Primary Health Properties, a REIT that owns clinics in the UK and Ireland. JPMorgan is currently selling 0.6% of this particular REIT’s share capital short. Should I sell before it’s too late?

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

Different strokes for different folks

I invested more than 10% of my portfolio in Primary Health Properties in early 2023. I made that move because I believe ageing demographics in the UK will cause demand for health services to skyrocket. It also sweetened the deal that the REIT was trading at a beaten-down price with a chunky dividend yield of 6.7%. I was left impressed by the fact the company has a 26-year streak in year-on-year dividend growth.

Traders at JPMorgan clearly don’t share my enthusiasm. Given Supermarket Income REIT is also on the list of most-shorted stocks, it could reflect in part pessimism towards the UK property market more generally. Indeed, the Bank of England might shock investors by raising interest rates again. In that case, UK REITs like Primary Healthcare Properties could experience a vicious bear market.

Comfortingly, I’m not alone in my optimism for UK REITs. Morgan Stanley called UK property stocks “compelling” in a research note back in October.

And, not to jinx it, but I’m pleased to report that – so far – most of JPMorgan’s shorts are in the red. Below are the nine shorted stocks along with their price changes since the position was opened.

Company NameShort position openedPrice change since short was opened (to 14 December 2023)
Essentra16-Nov-230.3%
FD Technologies05-Dec-238.6%
ME Group International08-Dec-23-0.4%
Pennon Group21-Aug-2319.63%
Primary Health Properties13-Oct-2314.2%
Renishaw07-Dec-230%
Supermarket Income REIT21-Jun-238.8%
The Gym Group19-May-230%
Financial Conduct Authority disclosures, as at 14 December 2023; price data from Yahoo Finance

Five of the nine positions have increased in price, the opposite of what JPMorgan had hoped. Two have flat-lined. One (ME Group International) has nudged down by -0.4%.

To conclude, I’ll be holding onto my shares in Primary Health Properties. I like the company’s financials and track record. I think it’s well positioned to ride some powerful demographic tailwinds over the next decade and beyond.

Mark Tovey has positions in Primary Health Properties Plc. The Motley Fool UK has recommended Primary Health Properties Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

How much do you need in an ISA to target £8,333 a month of passive income?

Our writer explores a potential route to earning double what is today considered a comfortable retirement and all tax-free inside…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Could these 3 FTSE 100 shares soar in 2026?

Our writer identifies a trio of FTSE 100 shares he thinks might potentially have more petrol in the tank as…

Read more »

Pakistani multi generation family sitting around a table in a garden in Middlesbourgh, North East of England.
Dividend Shares

How much do you need in a FTSE 250 dividend portfolio to make £14.2k of annual income?

Jon Smith explains three main factors that go into building a strong FTSE 250 dividend portfolio to help income investors…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

275 times earnings! Am I the only person who thinks Tesla’s stock price is over-inflated?

Using conventional measures, James Beard reckons the Tesla stock price is expensive. Here, he considers why so many people appear…

Read more »

Investing Articles

Here’s what I think investors in Nvidia stock can look forward to in 2026

Nvidia stock has delivered solid returns for investors in 2025. But it could head even higher in 2026, driven by…

Read more »

Investing Articles

Here are my top US stocks to consider buying in 2026

The US remains the most popular market for investors looking for stocks to buy. In a crowded market, where does…

Read more »

Investing Articles

£20,000 in excess savings? Here’s how to try and turn that into a second income in 2026

Stephen Wright outlines an opportunity for investors with £20,000 in excess cash to target a £1,450 a year second income…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is a 9% yield from one of the UK’s most reliable dividend shares too good to be true?

Taylor Wimpey’s recent dividend record has been outstanding, but investors thinking of buying shares need to take a careful look…

Read more »